Nothing Special   »   [go: up one dir, main page]

Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study

J Travel Med. 2008 Jan-Feb;15(1):25-30. doi: 10.1111/j.1708-8305.2007.00164.x.

Abstract

Background: There is little published information available describing rabies pre- and postexposure prophylaxis (PEP) in tourists returning to their home country and seeking care for animal-associated injuries, especially those associated with a rabies risk.

Method: We analyzed 261 travelers seeking care on returning to their home country following an animal-related injury acquired abroad. Information on individual cases of rabies (PEP) including preexposure status, type of contact with a potentially rabid animal, type of animal, and the nature of rabies PEP was collected by retrospectively analyzing records from May 1997 to May 2005.

Results: The majority of injuries were acquired in South-east Asia and North Africa. Only 6.8% of injured patients were previously vaccinated against rabies, while 75.4% of the cohort experienced a severe injurious contact with animals (World Health Organization category III). Of travelers who sustained a high-risk injury, only 24% received both vaccination and rabies immune globulin,(RIG) while 76% received vaccination only. Of the travelers who did not receive RIG, 43% had received a first dose of vaccine more than 7 days after return and before presenting to a clinic in their home country.

Conclusions: This study highlights important deficiencies in rabies PEP for travelers who acquire high-risk, animal-associated injuries in rabies-endemic countries, with the majority not receiving adequate PEP or experiencing a substantial delay before receiving rabies vaccination.

MeSH terms

  • Australia
  • France
  • Humans
  • Immunoglobulins / therapeutic use
  • New Zealand
  • Rabies / prevention & control*
  • Rabies Vaccines / therapeutic use
  • Retrospective Studies
  • Travel

Substances

  • Immunoglobulins
  • Rabies Vaccines